UBM India, organisers of CPhI and P-MEC India, the leading global pharma trade show and conference, today hosted the 4th Edition of PharmaLytica 2017 ( 11th – 12th August). The two day event was inaugurated today by Chief Guest Shri Jayesh Ranjan, Principal Secretary to Government of Telangana, Industries & Commerce (I&C) Department & Information Technology, Electronics and Communications (ITE&C) Department, in the presence of Guests of Honour, Dr. Rao Vadlamudi, President, Indian Pharmaceutical Association (IPA), Shri Madan Mohan Reddy, Chairman, Pharmexcil and Director, Aurobindo Pharma, Dr Ravi Uday Bhaskar, Director General, Pharmexcil, Mr. Avinash Talwar, Director & Head – Global Sourcing, Dr Reddy’s Laboratories, Mr. Chakravarthi AVPS, Managing Director at Ecobliss India Pvt Limited, Mr. Yogesh Mudras, Managing Director, UBM India and Mr Rahul Deshpande, Group Director, UBM India, at the HITEX Exhibition Center.
PharmaLytica 2017 is considered to be an ideal platform for pharma professionals from the Analytical & Bio Tech, Lab equipments & Lab Chemicals, Pharma Machinery and Packaging sub-sectors, to keep abreast with innovations in the growing businesses of India’s pharma industry. Over 100 exhibiting companies have participated for the first time at the show, reiterating its acknowledged pole position in the South.
The 4th edition of the expo has witnessed participation from over 150 exhibitors from across the country including notable industry players such as Standard Group of Companies, Sanitt Equipment & Machines, Gandhi Automations, Mack Pharmatech, S.K. Pharma Machinery, Sterimax Engineering, Utopia Optovision, Rahul Enterprises, Chemipack India, Shree Naina Glass, Komal Industries, Allpharm Technologies, Subodh Engineering, Kirloskar Pneumatic, Integrated Cleanroom Technology, Accura Pharmaquip Inos Technologies among others.
On the day one of the PharmaLytica, a series of insightful sessions were organized to discuss the growth phase of the Indian pharma industry, the challenges it faces and how it can again truly distinguish itself in the global pharma industry in the years to come. Having made a mark in the bulk drug sector, Indian pharma companies have also started focusing on R&D, drug inventions and investing in new age technology and machinery for an all round, faster and efficient growth.
In view of the increasing scrutiny by the Food and Drug Administrators, Mr.Tadashi Koshida, Overseas Sales & Technical Support, Asia Pacific, Fuji Electric, spoke about the key challenges faced by the pharma companies from food drug administrators authorities (FDA), importance of Data Integrity and the Do’s and Don’ts from the regulators perspective. Elaborating on the transformational change witnessed among the Indian pharma companies, Mr. G. Sunder, GM-DQA at NATCO Research Centre, spoke about the importance of the data analytics and QC laboratory regulatory inspections compliance. Other sessions included – Pharma Preservation in a Cold Storage by Mr. Gunna Kiran, CEO – Gubba Cold Storage, Camera Inspection System by Mr Kartik Khanna, Director, Shree Naina Glass, Validation – A bare necessity for Pharma Industry by Dr. Subbarao V. Kattamuri, Director- Head of Operations, India, Aztec Consulting, Innovation in Packaging by Mr. Vishesh Gupta, Director, P.R. Packaging Ltd. and FDA Approved Simulation for Pharma Industry by Mr. Srikanth Kankekar, Country Manager, Customer Solutions, CADEFM Engineering Services India Pvt. Ltd.
Speaking at the inauguration of the 4th edition of PharmaLytica, Mr. Yogesh Mudras, Managing Director, UBM India said, “Analytical, Bio-technology, Lab equipments, Pharma Machinery and Pharma Packaging in India is set for huge augmentation owing to quality, research, regulatory and environmental compliances. Therefore, the need of the hour for Indian industry players is to achieve maximum efficiency from the potential of today’s landscape with better product and service offerings. To further market these offerings to a wider audience and in-turn stimulate trade amongst this niche Pharma sector, UBM India brings the 4th edition of PharmaLytica which will not only enable the exhibitors and visitors to network and connect but will also help the pharma community to pick up the latest industry trends and inventions pertaining to these sectors with its power-packed conferences.”
Shri Jayesh Ranjan, Principal Secretary to Government of Telangana, Industries & Commerce (I&C) Department & Information Technology, Electronics and Communications (ITE&C) Department, said, “I would like to congratulate UBM India’s PharmaLytica for 4 successful years. It makes perfect sense to hold PharmaLytica in Hyderabad, as it is the pharma hub of India, and it gets to reiterate this claim with the setting up of the largest pharma city in the world, with over 15,000 acres space dedicated to all aspects of the industry. It is through huge forums as PharmaLytica where visitors and exhibitors can analyse how their work gets complemented by the building of a dedicated Pharma City. I am sure buyers and sellers will find PharmaLytica extremely insightful and fruitful, and I wish it all the best.
Mr Madan Mohan Reddy, Chairman Pharmexcil and Director, Aurobindo Pharma, said:
“We are at a crucial juncture where the pharma industry has to keep on upgrading its way of thinking, and innovating. There is no scope of sustainability otherwise. It has to understand the latest developments, analyse them and integrate them in the larger scheme of things. It is in such an environment that a platform like PharmaLytica helps to propel the industry forward. I must congratulate UBM for the professional way it has been are conducting the pharma expos worldwide and moving things in the right direction. I am delighted that one of the ways which a key body like Pharmexcil gets to proactively support the cause of the industry is through forums such as PharmaLytica.
Dr Rao Vadlamuri, President, Indian Pharmaceutical Association (IPA)::
I would like to convey my sense of gratitude to platforms such as PharmaLytica. It is absolutely essential that trade shows meet technocrats, and service providers meet manufacturers to get the complete picture and rise up to the challenges the pharma sector is giving rise to. UBM India is doing a wonderful job in the sector, and as President of IPA, I would say that while choosing Hyderabad as the venue is really justified, it would be great to approach other hubs in India that are rising as well. They too need all the exposure and support that a platform of this stature affords.
Mr. Gopal Malawade, Branch Head- Kirloskar Pneumatic Co. Ltd. said, “We are delighted to be a part of PharmaLytica 2017. It’s indeed a great platform for us to connect with our existing and potential customers from the pharma industry. Kirloskar Pneumatic is one of the leading suppliers of the refrigeration systems that are used for HVAC and various cooling applications. This year, we are showcasing our New Generation Series Vapour Absorption Chiller, which has already earned a leading position in the industry by offering considerable cost savings in CAPEX & OPEX for our clients.”
The event also featured an Innovation Gallery with eight participating companies showcasing their innovation and latest technology. The companies that represented under the Innovation Gallery are Biopharmax India Pvt. Ltd., Galaxy Sivtek Pvt. Ltd., Gandhi Automations Pvt. Ltd., Scientific Research Instruments Company Private Limited,S. K. Pharma Machinery Pvt. Ltd., Landsky Engineers Pvt. Ltd. and Orbit Technologies Pvt. Ltd., Hyderabad.
PharmaLytica 2017 is being held at a time of vital transformation for the pharma sector. Currently, the National Pharma Policy is being drafted by the Government to ensure, much like its far-sighted ‘Pharma Vision 2020’ campaign, that India emerges as a true global leader in drug manufacturing. Issues of affordability and availability of medicines through the Drug Price Control Order & the National Pharmaceutical Pricing Authority are being aggressively addressed, along with a reduction of approval time for new facilities, to boost investments. PharmaLytica 2017 will help the pharmaceutical community network, engage in significant levels of market intelligence and voice the combined opinion on these trending subjects.
The expo is well supported by associations that include Pharmexcil, The Association of Contract Research Organisations (ACRO), Confederation of Indian Pharmaceutical Industry (CiPi) and Bulk Drug Manufacturers Association (India) BDMA.
To know more about the event and register for a free entry to the event, visit – www.ubmindia.in/pharmalytica
About UBM India:
UBM India is India’s leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content-led conferences and seminars. UBM India hosts over 25 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia. For further details, please visit ubmindia.in.